Chinese company mandates that employees take part in vaccine experiments, violating the Nuremburg code of medical ethics


(Natural News) Clamped down by communist control, the Chinese people are being marched toward permanent bodily requirements — their DNA surrendered over to the state and their immune systems sacrificed to and engineered by pharmaceutical companies. In China, there are four major drug manufacturers working on a seasonal covid-19 inoculation — CanSino Biologics, the Wuhan Institute of Biological Products, Anhui Zhifei Longkema Biopharmaceutical, and Sinovac.

It is important to note that all previous attempts to develop a coronavirus vaccine for SARS and MERS have failed, causing immunohistopathologies and death in animals. Covid-19 vaccine trials are inherently risky experiments, but due to the level of communist control, blind compliance and willingness to give up bodily integrity, human rights are now threatened around the globe.

Chinese employees coerced to be guinea pigs for vaccine experiment — coercion coming to a workplace near you

Internal documents obtained by Epoch Times, reveal that a Chinese state-run company has just mandated some employees to take part in Sinovac’s upcoming vaccine trial. This non-consensual agreement is forcing employees to be guinea pigs for a specific pharmaceutical company. Throughout the world, employees have been coerced to do things to their bodies in order to keep their job and feed their families. Now these bodily requirements entail forced vaccines, a glimpse of what is to come as countries follow the lead of China and submit to a medical police state and communist control.

Sinovac’s untested vaccine is already being used in a coercive and forceful manner. The vaccine’s packaging clearly states that it has not been approved by China’s National Medical Products Administration (NMPA).

Chan King-ming, director of the Environmental Science Program at the Chinese University of Hong Kong and member of U.S. Society of Toxicology said that unapproved vaccines are risky. “The vaccine might not work,” he said, and in the worst case scenario, the vaccine “may infect people,” causing complications and the spread of the virus. The NMPA typically tests a vaccine in three phases during clinical trials before it is launched into the market. Even after approval, the vaccine isn’t perfect because each person’s immune system is unique and may respond differently to the lab-strain virus, the antigens, preservatives, heavy metals, foreign DNA, and other chemical ingredients.

“I want to ask: The vaccine isn’t approved. Who will take responsibility for the vaccine’s safety?” Chan said.